Il­lu­mi­na and Guardant agree to dis­miss lit­i­ga­tion, share spec­i­men sam­ples af­ter year-long le­gal bat­tle

Af­ter throw­ing ac­cu­sa­tions of re­tal­i­a­tion and steal­ing trade se­crets in court, Il­lu­mi­na and di­ag­nos­tics com­pa­ny Guardant Health have come to a three-year agree­ment that in­cludes a re­quest to joint­ly dis­miss the lit­i­ga­tion with prej­u­dice and brings the two com­pa­nies to­geth­er again to share spec­i­men sam­ples for can­cer re­search, Guardant said in a state­ment Tues­day.

The agree­ment in­cludes the dis­missal of al­le­ga­tions of any­thing to do with in­tel­lec­tu­al prop­er­ty, which is how the law­suit be­gan when Il­lu­mi­na filed a com­plaint against Helmy El­toukhy and Ami­rAli Ta­lasaz, two ex-staffers who found­ed Guardant. In the 2022 law­suit, Il­lu­mi­na al­leged that the pair stole com­pa­ny trade se­crets and used Il­lu­mi­na equip­ment, com­put­ers and email to launch Guardant.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER